acridine orange Search Results


95
MedChemExpress acridine orange staining
Acridine Orange Staining, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+hydrochloride/pm42174621-92-12-15
Average 95 stars, based on 1 article reviews
acridine orange staining - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Biotium 10 n nonyl acridine orange
10 N Nonyl Acridine Orange, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange/10__1038_slash_s41598___026___74998___z-62-36-41
Average 93 stars, based on 1 article reviews
10 n nonyl acridine orange - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

99
Beyotime reactive oxygen species ros assay kit
Reactive Oxygen Species Ros Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+Staining+Kit/pm37834468-365-93-102
Average 99 stars, based on 1 article reviews
reactive oxygen species ros assay kit - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

98
Thermo Fisher acridine orange
Acridine Orange, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange/bio_rxiv__64898__2026__05__18__725985-226-27-29
Average 98 stars, based on 1 article reviews
acridine orange - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

94
MedChemExpress acridine orange 10 nonyl bromide nao
Acridine Orange 10 Nonyl Bromide Nao, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+10-Nonyl+Bromide/bio_rxiv__2025__10__27__684888-272-9-14
Average 94 stars, based on 1 article reviews
acridine orange 10 nonyl bromide nao - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology nao
NMN effects on HepG2 cells exposed to hyperglycemic conditions: neutral lipids, polar <t>lipids,</t> <t>mitochondrial</t> mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange <t>(NAO).</t> ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; **** p < 0.0001.
Nao, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+10-nonyl+bromide/pmc10932336-359-9-11
Average 93 stars, based on 1 article reviews
nao - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
MedChemExpress acridine orange
NMN effects on HepG2 cells exposed to hyperglycemic conditions: neutral lipids, polar <t>lipids,</t> <t>mitochondrial</t> mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange <t>(NAO).</t> ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; **** p < 0.0001.
Acridine Orange, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+base/pm37391428-368-0-2
Average 94 stars, based on 1 article reviews
acridine orange - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
ImmunoChemistry Technologies acridine orange ao
NMN effects on HepG2 cells exposed to hyperglycemic conditions: neutral lipids, polar <t>lipids,</t> <t>mitochondrial</t> mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange <t>(NAO).</t> ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; **** p < 0.0001.
Acridine Orange Ao, supplied by ImmunoChemistry Technologies, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+Fluorescent+Staining+Solution/pm29795139-188-12-15
Average 91 stars, based on 1 article reviews
acridine orange ao - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology acridine orange hemi zinc chloride salt
NMN effects on HepG2 cells exposed to hyperglycemic conditions: neutral lipids, polar <t>lipids,</t> <t>mitochondrial</t> mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange <t>(NAO).</t> ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; **** p < 0.0001.
Acridine Orange Hemi Zinc Chloride Salt, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+hemi(zinc+chloride)+salt/pmc12752020-6-0-7
Average 93 stars, based on 1 article reviews
acridine orange hemi zinc chloride salt - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Thermo Fisher acridine orange solution
NMN effects on HepG2 cells exposed to hyperglycemic conditions: neutral lipids, polar <t>lipids,</t> <t>mitochondrial</t> mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange <t>(NAO).</t> ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; **** p < 0.0001.
Acridine Orange Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acridine+orange/Acridine+Orange+Staining+Solution/pmc07604347-295-7-10
Average 94 stars, based on 1 article reviews
acridine orange solution - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


NMN effects on HepG2 cells exposed to hyperglycemic conditions: neutral lipids, polar lipids, mitochondrial mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange (NAO). ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; **** p < 0.0001.

Journal: International Journal of Molecular Sciences

Article Title: Nicotinamide Mononucleotide (NMN) Works in Type 2 Diabetes through Unexpected Effects in Adipose Tissue, Not by Mitochondrial Biogenesis

doi: 10.3390/ijms25052594

Figure Lengend Snippet: NMN effects on HepG2 cells exposed to hyperglycemic conditions: neutral lipids, polar lipids, mitochondrial mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange (NAO). ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; **** p < 0.0001.

Article Snippet: The fluorescent markers used were as follows: 10 nM NAO (sc-214487, Santa Cruz Biotechnology, Dallas, Texas, USA) for mitochondrial mass, 25 nM MitoView Red for mitochondrial function, 2 μg/mL JC-1 for mitochondrial membrane potential, 2.8 μg/mL DHR123 for mitochondrial ROS, and 100 ng/mL Nile Red (7726.1, Carl Roth, Karlsruhe, Germany) for neutral and polar lipids.

Techniques: Activity Assay, Membrane, Fluorescence, Microscopy, Flow Cytometry, Standard Deviation

NMN effects on C2C12-derived myotubes exposed to hyperglycemic conditions: neutral lipids, polar lipids, mitochondrial mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange (NAO). ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Journal: International Journal of Molecular Sciences

Article Title: Nicotinamide Mononucleotide (NMN) Works in Type 2 Diabetes through Unexpected Effects in Adipose Tissue, Not by Mitochondrial Biogenesis

doi: 10.3390/ijms25052594

Figure Lengend Snippet: NMN effects on C2C12-derived myotubes exposed to hyperglycemic conditions: neutral lipids, polar lipids, mitochondrial mass, metabolic activity, membrane potential, and reactive oxygen species (ROS). ( A ) Mitochondrial mass with 10-nonyl-acridine orange (NAO). ( B ) Neutral lipids with Nile Red (FL2). ( C ) Polar lipids with Nile Red (FL5). ( D ) Fluorescence microscopy. Scale bars, 50 μm. ( E ) Mitochondrial function with MitoView Red. ( F ) Mitochondrial membrane potential with JC-1. ( G ) Mitochondrial ROS with DHR-123 in C2C12 myotubes during 100 μM NMN treatment in normoglycemic conditions (NN), hyperglycemic conditions followed by culture media switch to normoglycemic conditions during NMN treatment (HN), hyperglycemic conditions before and during treatment (HH), versus untreated condition (−). The flow cytometry data are illustrated as average values of the groups ( n = 3 × 15,000 events) ± standard deviation of the mean (STDEV) and statistical significance between NMN-treated and untreated conditions. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Article Snippet: The fluorescent markers used were as follows: 10 nM NAO (sc-214487, Santa Cruz Biotechnology, Dallas, Texas, USA) for mitochondrial mass, 25 nM MitoView Red for mitochondrial function, 2 μg/mL JC-1 for mitochondrial membrane potential, 2.8 μg/mL DHR123 for mitochondrial ROS, and 100 ng/mL Nile Red (7726.1, Carl Roth, Karlsruhe, Germany) for neutral and polar lipids.

Techniques: Derivative Assay, Activity Assay, Membrane, Fluorescence, Microscopy, Flow Cytometry, Standard Deviation